US Patent 7838676 Beta-secretase modulators and methods of use
Patent 7838676 was granted and assigned to Amgen on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+307 characters)
Article
Patent abstract
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07838676 Beta-secretase modulators and methods of use US Patent 7838676 Beta-secretase modulators and methods of use
Infobox
Patent Number
0783867600
Patent Number
783867600
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078386760
Date of Patent
November 23, 2010
0Patent Application Number
115999010
Date Filed
November 14, 2006
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078386760
Date of Patent
November 23, 2010
0Patent Application Number
115999010
Date Filed
November 14, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07838676 Beta-secretase modulators and methods of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07838676
Date of patent
November 23, 2010
Patent application number
11599901
Date Filed
November 14, 2006
Patent primary examiner
Find more entities like US Patent 7838676 Beta-secretase modulators and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.